KLRK1 and cancer: A pro-inflammatory environment also contributes to NKG2D down-regulation, as release of the pro-inflammatory macrophage migration inhibitory factor (MIF) after inflammatory stimuli [81,82], contributes to NKG2D down-regulation and impaired NK cell cytotoxicity in cancer patients [83].